Literature DB >> 10661731

The epidemiology of bacterial vaginosis.

G P Schmid1.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10661731     DOI： 10.1016/s0020-7292(99)00133-2

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN： 0020-7292            Impact factor:   3.561


× No keyword cloud information.
  8 in total

Review 1.  Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective.

Authors:  Rebecca M Brotman
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

2.  Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics.

Authors:  Rebecca M Brotman; Emily J Erbelding; Roxanne M Jamshidi; Mark A Klebanoff; Jonathan M Zenilman; Khalil G Ghanem
Journal:  J Pediatr Adolesc Gynecol       Date:  2007-08       Impact factor: 1.814

3.  Characteristics and pregnancy outcomes of pregnant women asymptomatic for bacterial vaginosis.

Authors:  Deborah B Nelson; Scarlett Bellamy; Bonnie A Clothier; George A Macones; Irving Nachamkin; Althea Ruffin; Lynne Allen-Taylor; Frank K Friedenberg
Journal:  Matern Child Health J       Date:  2007-06-02

4.  A longitudinal study of vaginal douching and bacterial vaginosis--a marginal structural modeling analysis.

Authors:  Rebecca M Brotman; Mark A Klebanoff; Tonja R Nansel; William W Andrews; Jane R Schwebke; Jun Zhang; Kai F Yu; Jonathan M Zenilman; Daniel O Scharfstein
Journal:  Am J Epidemiol       Date:  2008-05-23       Impact factor: 4.897

5.  Stress, bacterial vaginosis, and the role of immune processes.

Authors:  Jennifer F Culhane; Virginia A Rauh; Robert L Goldenberg
Journal:  Curr Infect Dis Rep       Date:  2006-11       Impact factor: 3.663

6.  In silico vs in vitro analysis of primer specificity for the detection of Gardnerella vaginalis, Atopobium vaginae and Lactobacillus spp.

Authors:  Ana Henriques; Tatiana Cereija; António Machado; Nuno Cerca
Journal:  BMC Res Notes       Date:  2012-11-15

7.  BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial.

Authors:  Melinda Zeron Mullins; Konia M Trouton
Journal:  Trials       Date:  2015-07-26       Impact factor: 2.279

8.  A Clinicopathological Diagnostic and Therapeutic Approach to Cytolytic Vaginosis: An Extremely Rare Entity that may Mimic Vulvovaginal Candidiasis.

Authors:  Uguray P Hacısalihoğlu; Ferruh Acet
Journal:  J Cytol       Date:  2021-05-08       Impact factor: 1.000
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.